Statistics
Publications
9
Citations
817
H-Index
9
Active since
2002
Wenxian Wang is an author at AstraZeneca (United States) specializing in life sciences, oncology, and molecular oncology.
Publications per year
2002–2022
9
9
Potent and selective bivalent inhibitors of BET bromodomains
Michael J. Waring, Huawei Chen, Alfred A. Rabow et al. · Nature Chemical Biology · 2016 · 135 citations · Full text
Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1
Jiaquan Wu, Keith Mikule, Wenxian Wang et al. · ACS Chemical Biology · 2013 · 123 citations
1–5 of 9